Ask AI
ALPINE Long Term Extension
Phase III ALPINE Long-Term Extension Study of Zanabrutinib in Patients With Relapsed or Refractory CLL/SLL

Released: December 19, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 19, 2025